Published in Mol Cell Biol on February 01, 1990
The human splicing factors ASF/SF2 and SC35 possess distinct, functionally significant RNA binding specificities. EMBO J (1995) 4.66
A small element from the Mason-Pfizer monkey virus genome makes human immunodeficiency virus type 1 expression and replication Rev-independent. Proc Natl Acad Sci U S A (1994) 4.43
SR proteins promote the first specific recognition of Pre-mRNA and are present together with the U1 small nuclear ribonucleoprotein particle in a general splicing enhancer complex. Mol Cell Biol (1994) 4.25
Alternative splicing of human immunodeficiency virus type 1 mRNA modulates viral protein expression, replication, and infectivity. J Virol (1993) 3.90
Mechanism of action of regulatory proteins encoded by complex retroviruses. Microbiol Rev (1992) 3.60
The cardiac troponin T alternative exon contains a novel purine-rich positive splicing element. Mol Cell Biol (1993) 3.48
Distinct RNA sequences in the gag region of human immunodeficiency virus type 1 decrease RNA stability and inhibit expression in the absence of Rev protein. J Virol (1992) 3.44
Polypurine sequences within a downstream exon function as a splicing enhancer. Mol Cell Biol (1994) 3.15
Mutational inactivation of an inhibitory sequence in human immunodeficiency virus type 1 results in Rev-independent gag expression. J Virol (1992) 3.14
Kinetics of expression of multiply spliced RNA in early human immunodeficiency virus type 1 infection of lymphocytes and monocytes. Proc Natl Acad Sci U S A (1991) 2.81
A systematic analysis of the factors that determine the strength of pre-mRNA splicing enhancers. EMBO J (1998) 2.71
Identification of positive and negative splicing regulatory elements within the terminal tat-rev exon of human immunodeficiency virus type 1. Mol Cell Biol (1995) 2.55
Presence of exon splicing silencers within human immunodeficiency virus type 1 tat exon 2 and tat-rev exon 3: evidence for inhibition mediated by cellular factors. Mol Cell Biol (1995) 2.51
Nonsense codons within the Rous sarcoma virus gag gene decrease the stability of unspliced viral RNA. Mol Cell Biol (1991) 2.42
Presence of negative and positive cis-acting RNA splicing elements within and flanking the first tat coding exon of human immunodeficiency virus type 1. Mol Cell Biol (1994) 2.35
Selection of novel exon recognition elements from a pool of random sequences. Mol Cell Biol (1995) 2.27
Identification and characterization of intragenic sequences which repress human immunodeficiency virus structural gene expression. J Virol (1991) 2.26
A structured retroviral RNA element that mediates nucleocytoplasmic export of intron-containing RNA. Mol Cell Biol (1997) 2.07
Expression of alternatively spliced human T-lymphotropic virus type I pX mRNA in infected cell lines and in primary uncultured cells from patients with adult T-cell leukemia/lymphoma and healthy carriers. Proc Natl Acad Sci U S A (1992) 2.05
A 32-nucleotide exon-splicing enhancer regulates usage of competing 5' splice sites in a differential internal exon. Mol Cell Biol (1995) 1.92
Identification of a Rev-related protein by analysis of spliced transcripts of the human endogenous retroviruses HTDV/HERV-K. J Virol (1995) 1.91
The tat/rev intron of human immunodeficiency virus type 1 is inefficiently spliced because of suboptimal signals in the 3' splice site. J Virol (1994) 1.87
Avian retroviral RNA element promotes unspliced RNA accumulation in the cytoplasm. J Virol (1996) 1.85
Intronic sequences and 3' splice sites control Rous sarcoma virus RNA splicing. J Virol (1992) 1.79
The basic domain of Rev from human immunodeficiency virus type 1 specifically blocks the entry of U4/U6.U5 small nuclear ribonucleoprotein in spliceosome assembly. J Virol (1993) 1.65
The retrovirus RNA trafficking granule: from birth to maturity. Retrovirology (2006) 1.63
Splicing efficiency of human immunodeficiency virus type 1 tat RNA is determined by both a suboptimal 3' splice site and a 10 nucleotide exon splicing silencer element located within tat exon 2. Nucleic Acids Res (1997) 1.61
Elements regulating an alternatively spliced exon of the rat fibronectin gene. Mol Cell Biol (1993) 1.54
A sequence compilation and comparison of exons that are alternatively spliced in neurons. Nucleic Acids Res (1994) 1.50
SR protein splicing factors interact with the Rous sarcoma virus negative regulator of splicing element. J Virol (1996) 1.49
Identification of the sequences responsible for the splicing phenotype of the regulatory intron of the L1 ribosomal protein gene of Xenopus laevis. Mol Cell Biol (1992) 1.45
The exon splicing silencer in human immunodeficiency virus type 1 Tat exon 3 is bipartite and acts early in spliceosome assembly. Mol Cell Biol (1998) 1.44
The sequence complementarity between HIV-1 5' splice site SD4 and U1 snRNA determines the steady-state level of an unstable env pre-mRNA. RNA (2001) 1.42
The Rev protein of human immunodeficiency virus type 1 counteracts the effect of an AU-rich negative element in the human papillomavirus type 1 late 3' untranslated region. J Virol (1995) 1.40
Selection of the bovine papillomavirus type 1 nucleotide 3225 3' splice site is regulated through an exonic splicing enhancer and its juxtaposed exonic splicing suppressor. J Virol (1996) 1.39
Molecular genetic dissection of mouse unconventional myosin-VA: tail region mutations. Genetics (1998) 1.38
The blocks to human immunodeficiency virus type 1 Tat and Rev functions in mouse cell lines are independent. J Virol (1993) 1.34
Antagonism between RSF1 and SR proteins for both splice-site recognition in vitro and Drosophila development. Genes Dev (1999) 1.31
A naturally arising mutation of a potential silencer of exon splicing in human immunodeficiency virus type 1 induces dominant aberrant splicing and arrests virus production. J Virol (1997) 1.31
Identification of cis-acting intron and exon regions in influenza virus NS1 mRNA that inhibit splicing and cause the formation of aberrantly sedimenting presplicing complexes. Mol Cell Biol (1992) 1.23
U1 small nuclear ribonucleoprotein and splicing inhibition by the rous sarcoma virus negative regulator of splicing element. J Virol (1999) 1.22
Two distant upstream regions containing cis-acting signals regulating splicing facilitate 3'-end processing of avian sarcoma virus RNA. J Virol (1992) 1.17
An RNA splicing enhancer-like sequence is a component of a splicing inhibitor element from Rous sarcoma virus. Mol Cell Biol (1998) 1.17
An exonic splicing silencer downstream of the 3' splice site A2 is required for efficient human immunodeficiency virus type 1 replication. J Virol (2005) 1.17
Equine infectious anemia virus trans-regulatory protein Rev controls viral mRNA stability, accumulation, and alternative splicing. J Virol (1994) 1.15
Mutations in the regions of the Rous sarcoma virus 3' splice sites: implications for regulation of alternative splicing. J Virol (1991) 1.14
The mechanisms controlling ribosomal protein L1 pre-mRNA splicing are maintained in evolution and rely on conserved intron sequences. Nucleic Acids Res (1992) 1.11
R region sequences in the long terminal repeat of a murine retrovirus specifically increase expression of unspliced RNAs. J Virol (1999) 1.10
The role of overlapping U1 and U11 5' splice site sequences in a negative regulator of splicing. RNA (1999) 1.09
Regulation of the extent of splicing of influenza virus NS1 mRNA: role of the rates of splicing and of the nucleocytoplasmic transport of NS1 mRNA. Mol Cell Biol (1991) 1.08
A secondary structure that contains the 5' and 3' splice sites suppresses splicing of duck hepatitis B virus pregenomic RNA. J Virol (2002) 1.06
Purine-rich enhancers function in the AT-AC pre-mRNA splicing pathway and do so independently of intact U1 snRNP. RNA (1998) 1.05
Genetic selection for balanced retroviral splicing: novel regulation involving the second step can be mediated by transitions in the polypyrimidine tract. Mol Cell Biol (1995) 1.04
Exonic splicing enhancers in fission yeast: functional conservation demonstrates an early evolutionary origin. Genes Dev (2004) 1.02
Characterization of U2AF(6), a splicing factor related to U2AF(35). Mol Cell Biol (2002) 1.01
Retroviral splicing suppressor sequesters a 3' splice site in a 50S aberrant splicing complex. Mol Cell Biol (2005) 1.00
A suboptimal 5' splice site is a cis-acting determinant of nuclear export of polyomavirus late mRNAs. Mol Cell Biol (1996) 1.00
CA- and purine-rich elements form a novel bipartite exon enhancer which governs inclusion of the minute virus of mice NS2-specific exon in both singly and doubly spliced mRNAs. Mol Cell Biol (1999) 0.98
Serine/arginine-rich proteins contribute to negative regulator of splicing element-stimulated polyadenylation in rous sarcoma virus. J Virol (2007) 0.98
Alternative splicing of pre-mRNAs encoding the nonstructural proteins of minute virus of mice is facilitated by sequences within the downstream intron. J Virol (1994) 0.97
Inhibition of RNA splicing at the Rous sarcoma virus src 3' splice site is mediated by an interaction between a negative cis element and a chicken embryo fibroblast nuclear factor. J Virol (1995) 0.95
Possible role of splice acceptor site in expression of unspliced gag-containing message of Moloney murine leukemia virus. J Virol (1996) 0.93
The negative regulator of splicing element of Rous sarcoma virus promotes polyadenylation. J Virol (2006) 0.92
Genetic determinant of rapid-onset B-cell lymphoma by avian leukosis virus. J Virol (1997) 0.92
Silent point mutation in an avian retrovirus RNA processing element promotes c-myb-associated short-latency lymphomas. J Virol (2003) 0.90
Branchpoint and polypyrimidine tract mutations mediating the loss and partial recovery of the Moloney murine sarcoma virus MuSVts110 thermosensitive splicing phenotype. J Virol (1995) 0.90
Role of Nucleocytoplasmic RNA Transport during the Life Cycle of Retroviruses. Front Microbiol (2012) 0.90
Human T-cell leukemia virus type 2 Rex inhibits pre-mRNA splicing in vitro at an early stage of spliceosome formation. J Virol (1996) 0.89
Selection and characterization of replication-competent revertants of a Rous sarcoma virus src gene oversplicing mutant. J Virol (1996) 0.88
Expression of intracisternal A-particle-related retroviral element-encoded envelope proteins detected in cell lines. J Virol (1992) 0.87
A premature termination codon mutation at the C terminus of foamy virus Gag downregulates the levels of spliced pol mRNA. J Virol (2007) 0.85
Selective inhibition of splicing at the avian sarcoma virus src 3' splice site by direct-repeat posttranscriptional cis elements. J Virol (2000) 0.84
Retroviral splicing suppressor requires three nonconsensus uridines in a 5' splice site-like sequence. J Virol (2001) 0.84
cis-Acting inhibitory elements within the pol-env region of human T-cell leukemia virus type 1 possibly involved in viral persistence. J Virol (1997) 0.84
Contrasted cis-acting effects of downstream 5' splice sites on the splicing of a retained intron: the adenoviral E1A pre-mRNA model. Nucleic Acids Res (1993) 0.82
Activation of cryptic splice sites in murine sarcoma virus-124 mutants. J Virol (1990) 0.82
Posttranscriptional regulation of retroviral gene expression: primary RNA transcripts play three roles as pre-mRNA, mRNA, and genomic RNA. Wiley Interdiscip Rev RNA (2013) 0.82
cis Elements required for high-level expression of unspliced Gag-containing message in Moloney murine leukemia virus. J Virol (1998) 0.80
The Moloney murine sarcoma virus ts110 5' splice site signal contributes to the regulation of splicing efficiency and thermosensitivity. J Virol (1996) 0.80
RNA processing control in avian retroviruses. Front Biosci (2008) 0.80
Translation of MMTV Gag requires nuclear events involving splicing motifs in addition to the viral Rem protein and RmRE. Retrovirology (2012) 0.79
Repair of a Rev-minus human immunodeficiency virus type 1 mutant by activation of a cryptic splice site. J Virol (2001) 0.79
Juxtaposition of two distant, serine-arginine-rich protein-binding elements is required for optimal polyadenylation in Rous sarcoma virus. J Virol (2011) 0.79
Structural and functional analysis of the Rous Sarcoma virus negative regulator of splicing and demonstration of its activation by the 9G8 SR protein. Nucleic Acids Res (2010) 0.75
Evidence that a threshold of serine/arginine-rich (SR) proteins recruits CFIm to promote rous sarcoma virus mRNA 3' end formation. Virology (2016) 0.75
Selective extraction of polyoma DNA from infected mouse cell cultures. J Mol Biol (1967) 106.91
Nucleotide sequence of Rous sarcoma virus. Cell (1983) 17.80
Splicing of messenger RNA precursors. Annu Rev Biochem (1986) 14.41
Isolation and properties of Moloney murine leukemia virus mutants: use of a rapid assay for release of virion reverse transcriptase. J Virol (1981) 13.11
Use of eukaryotic expression technology in the functional analysis of cloned genes. Methods Enzymol (1987) 12.66
Pre-mRNA splicing. Annu Rev Genet (1986) 9.86
The role of small nuclear ribonucleoprotein particles in pre-mRNA splicing. Nature (1987) 8.28
Splicing of messenger RNA precursors. Science (1987) 7.61
A role for exon sequences and splice-site proximity in splice-site selection. Cell (1986) 6.41
Alternative splicing: a ubiquitous mechanism for the generation of multiple protein isoforms from single genes. Annu Rev Biochem (1987) 5.79
Some cis- and trans-acting mutants for splicing target pre-mRNA to the cytoplasm. Cell (1989) 5.46
A minimal intron length but no specific internal sequence is required for splicing the large rabbit beta-globin intron. Cell (1984) 5.37
Alternative splicing caused by RNA secondary structure. Cell (1985) 4.21
A conserved cis-acting sequence in the 5' leader of avian sarcoma virus RNA is required for packaging. J Virol (1986) 3.95
Cryptic branch point activation allows accurate in vitro splicing of human beta-globin intron mutants. Cell (1985) 3.25
The role of the mammalian branchpoint sequence in pre-mRNA splicing. Genes Dev (1988) 3.14
Regulation of Rous sarcoma virus RNA splicing and stability. Mol Cell Biol (1988) 2.92
Factors influencing alternative splice site utilization in vivo. Mol Cell Biol (1987) 2.39
Exon mutations that affect the choice of splice sites used in processing the SV40 late transcripts. Nucleic Acids Res (1985) 2.28
Regulation of HIV and HTLV gene expression. Genes Dev (1988) 2.19
Multiple regions in the Rous sarcoma virus src gene intron act in cis to affect the accumulation of unspliced RNA. J Virol (1989) 1.95
cis-acting intron mutations that affect the efficiency of avian retroviral RNA splicing: implication for mechanisms of control. J Virol (1988) 1.88
Nonconsensus branch-site sequences in the in vitro splicing of transcripts of mutant rabbit beta-globin genes. Proc Natl Acad Sci U S A (1985) 1.82
Synthesis and processing of avian sarcoma retrovirus RNA. Adv Virus Res (1988) 1.79
Differences in intracellular DNA ligation after microinjection and transfection. Mol Cell Biol (1984) 1.73
Noncoding region between the env and src genes of Rous sarcoma virus influences splicing efficiency at the src gene 3' splice site. J Virol (1987) 1.68
The role of the polypyrimidine stretch at the SV40 early pre-mRNA 3' splice site in alternative splicing. EMBO J (1988) 1.66
Avian sarcoma virus gag and env gene structural protein precursors contain a common amino-terminal sequence. Proc Natl Acad Sci U S A (1984) 1.55
Inhibition of splicing but not cleavage at the 5' splice site by truncating human beta-globin pre-mRNA. Proc Natl Acad Sci U S A (1986) 1.51
Alterations in the transport and processing of Rous sarcoma virus envelope glycoproteins mutated in the signal and anchor regions. J Cell Biochem (1983) 1.31
A C-terminal domain in the avian sarcoma-leukosis virus pol gene product is not essential for viral replication. J Virol (1988) 1.30
In vitro splicing of influenza viral NS1 mRNA and NS1-beta-globin chimeras: possible mechanisms for the control of viral mRNA splicing. Proc Natl Acad Sci U S A (1986) 1.25
Transforming viruses spontaneously arise from nontransforming reticuloendotheliosis virus strain T-derived viruses as a result of increased accumulation of spliced viral RNA. J Virol (1988) 1.15
The avian retroviral IN protein is both necessary and sufficient for integrative recombination in vitro. Cell (1990) 7.19
The avian retroviral integration protein cleaves the terminal sequences of linear viral DNA at the in vivo sites of integration. J Virol (1989) 6.83
Residues critical for retroviral integrative recombination in a region that is highly conserved among retroviral/retrotransposon integrases and bacterial insertion sequence transposases. Mol Cell Biol (1992) 6.77
Standardized and simplified nomenclature for proteins common to all retroviruses. J Virol (1988) 6.31
Retroviral integrase domains: DNA binding and the recognition of LTR sequences. Nucleic Acids Res (1991) 4.39
The retroviral enzymes. Annu Rev Biochem (1994) 4.21
A conserved cis-acting sequence in the 5' leader of avian sarcoma virus RNA is required for packaging. J Virol (1986) 3.95
Nucleotide sequence analysis of the long terminal repeat (LTR) of avian retroviruses: structural similarities with transposable elements. Cell (1980) 3.53
Nucleotide sequence of acceptor site and termini of integrated avian endogenous provirus ev1: integration creates a 6 bp repeat of host DNA. Cell (1981) 3.10
HTLV-III gag protein is processed in yeast cells by the virus pol-protease. Science (1986) 3.06
Nucleotide sequence of noncoding regions in Rous-associated virus-2: comparisons delineate conserved regions important in replication and oncogenesis. J Virol (1984) 2.71
A role for DNA-PK in retroviral DNA integration. Science (1999) 2.68
Avian sarcoma and leukosis virus pol-endonuclease recognition of the tandem long terminal repeat junction: minimum site required for cleavage is also required for viral growth. J Virol (1987) 2.62
The role of branchpoint and 3'-exon sequences in the control of balanced splicing of avian retrovirus RNA. Genes Dev (1991) 2.58
Generation of diversity in retroviruses. Annu Rev Genet (1990) 2.53
Retroviral integrase functions as a multimer and can turn over catalytically. J Biol Chem (1992) 2.48
Viral DNA synthesized in vitro by avian retrovirus particles permeabilized with melittin. I. Kinetics of synthesis and size of minus- and plus-strand transcripts. J Virol (1981) 2.45
Selective cleavage in the avian retroviral long terminal repeat sequence by the endonuclease associated with the alpha beta form of avian reverse transcriptase. Proc Natl Acad Sci U S A (1983) 2.40
Retroviral DNA H structures: displacement-assimilation model of recombination. Cell (1982) 2.37
Identification and characterization of intragenic sequences which repress human immunodeficiency virus structural gene expression. J Virol (1991) 2.26
Complete nucleotide sequence of the influenza A/PR/8/34 virus NS gene and comparison with the NS genes of the A/Udorn/72 and A/FPV/Rostock/34 strains. Nucleic Acids Res (1980) 2.25
Site-directed mutagenesis of the avian retrovirus nucleocapsid protein, pp 12. Mutation which affects RNA binding in vitro blocks viral replication. J Biol Chem (1988) 2.25
High-resolution structure of the catalytic domain of avian sarcoma virus integrase. J Mol Biol (1995) 2.16
Isolation and characterization of recombinant DNA clones of avian retroviruses: size heterogeneity and instability of the direct repeat. J Virol (1980) 2.15
HIV-1 integrase: structural organization, conformational changes, and catalysis. Adv Virus Res (1999) 2.06
Properties of avian sarcoma-leukosis virus pp32-related pol-endonucleases produced in Escherichia coli. J Virol (1988) 2.03
DNA replication--bacteriophage lambda. Curr Top Microbiol Immunol (1977) 1.92
Endogenous avian retroviruses contain deficient promoter and leader sequences. Proc Natl Acad Sci U S A (1983) 1.90
Sequence comparison in the crossover region of an oncogenic avian retrovirus recombinant and its nononcogenic parent: genetic regions that control growth rate and oncogenic potential. Mol Cell Biol (1982) 1.89
cis-acting intron mutations that affect the efficiency of avian retroviral RNA splicing: implication for mechanisms of control. J Virol (1988) 1.88
Viral DNA synthesized in vitro by avian retrovirus particles permeabilized with melittin. II. Evidence for a strand displacement mechanism in plus-strand synthesis. J Virol (1981) 1.87
Proteolytic processing of avian sarcoma and leukosis viruses pol-endo recombinant proteins reveals another pol gene domain. J Virol (1987) 1.85
Mutagenesis of the Ha-ras oncogene in mouse skin tumors induced by polycyclic aromatic hydrocarbons. Proc Natl Acad Sci U S A (1986) 1.83
Comparison between the viral transforming gene (src) of recovered avian sarcoma virus and its cellular homolog. Mol Cell Biol (1981) 1.78
Concerted integration of linear retroviral DNA by the avian sarcoma virus integrase in vitro: dependence on both long terminal repeat termini. J Virol (1996) 1.72
HMG protein family members stimulate human immunodeficiency virus type 1 and avian sarcoma virus concerted DNA integration in vitro. J Virol (1999) 1.71
Molecular analysis of the c-myc locus in normal tissue and in avian leukosis virus-induced lymphomas. J Virol (1982) 1.70
The catalytic domain of avian sarcoma virus integrase: conformation of the active-site residues in the presence of divalent cations. Structure (1996) 1.64
A covalent complex between retroviral integrase and nicked substrate DNA. Proc Natl Acad Sci U S A (1991) 1.61
Molecular modeling of the HIV-1 protease and its substrate binding site. Science (1989) 1.60
Retroviral integrase, putting the pieces together. J Biol Chem (1996) 1.58
HIV DNA integration: observations and interferences. J Acquir Immune Defic Syndr (1990) 1.54
Molecular mechanisms in retrovirus DNA integration. Antiviral Res (1997) 1.54
Wortmannin potentiates integrase-mediated killing of lymphocytes and reduces the efficiency of stable transduction by retroviruses. Mol Cell Biol (2001) 1.53
Intracellular expression of single-chain variable fragments to inhibit early stages of the viral life cycle by targeting human immunodeficiency virus type 1 integrase. J Virol (1996) 1.50
Assembly and processing of avian retroviral gag polyproteins containing linked protease dimers. J Virol (1991) 1.48
Products of reverse transcription in avian retrovirus analyzed by electron microscopy. J Virol (1982) 1.47
Binding of different divalent cations to the active site of avian sarcoma virus integrase and their effects on enzymatic activity. J Biol Chem (1997) 1.47
Role of the avian retrovirus mRNA leader in expression: evidence for novel translational control. Mol Cell Biol (1986) 1.47
Targeting of retroviral integrase by fusion to a heterologous DNA binding domain: in vitro activities and incorporation of a fusion protein into viral particles. Virology (1996) 1.45
Synthetic peptides as substrates and inhibitors of a retroviral protease. Proc Natl Acad Sci U S A (1988) 1.41
Genetic recombination in avian retroviruses. J Cell Biochem (1982) 1.37
Multimerization determinants reside in both the catalytic core and C terminus of avian sarcoma virus integrase. J Biol Chem (1995) 1.35
Activity of avian retroviral protease expressed in Escherichia coli. J Virol (1988) 1.34
Subcellular localization of avian sarcoma virus and human immunodeficiency virus type 1 integrases. J Virol (1997) 1.34
A C-terminal domain in the avian sarcoma-leukosis virus pol gene product is not essential for viral replication. J Virol (1988) 1.30
Avian retroviral protease and cellular aspartic proteases are distinguished by activities on peptide substrates. J Biol Chem (1989) 1.29
Biological activity of cloned retroviral DNA in microinjected cells. Proc Natl Acad Sci U S A (1981) 1.29
Regulation of the human c-myc gene: 5' noncoding sequences do not affect translation. Mol Cell Biol (1985) 1.26
Terminal nucleotides of the preintegrative linear form of HIV-1 DNA deduced from the sequence of circular DNA junctions. J Acquir Immune Defic Syndr (1990) 1.26
Structure of the catalytic domain of avian sarcoma virus integrase with a bound HIV-1 integrase-targeted inhibitor. Proc Natl Acad Sci U S A (1998) 1.25
A preferred target DNA structure for retroviral integrase in vitro. J Biol Chem (1998) 1.24
Requirement for a conserved serine in both processing and joining activities of retroviral integrase. Proc Natl Acad Sci U S A (1992) 1.20
Analysis of substrate interactions of the Rous sarcoma virus wild type and mutant proteases and human immunodeficiency virus-1 protease using a set of systematically altered peptide substrates. J Biol Chem (1992) 1.20
Mutations that alter the activity of the Rous sarcoma virus protease. J Biol Chem (1992) 1.20
Modeling the late steps in HIV-1 retroviral integrase-catalyzed DNA integration. J Biol Chem (2000) 1.19
Activities and substrate specificity of the evolutionarily conserved central domain of retroviral integrase. Virology (1995) 1.18
Processing of avian retroviral gag polyprotein precursors is blocked by a mutation at the NC-PR cleavage site. J Virol (1992) 1.18
A range of catalytic efficiencies with avian retroviral protease subunits genetically linked to form single polypeptide chains. J Biol Chem (1991) 1.15
A metal-induced conformational change and activation of HIV-1 integrase. J Biol Chem (1997) 1.12
Monoclonal antibodies against HIV type 1 integrase: clues to molecular structure. AIDS Res Hum Retroviruses (1994) 1.09
Molecular mechanism of retroviral DNA integration. Pharmacol Ther (1994) 1.08
Structural determinants of metal-induced conformational changes in HIV-1 integrase. J Biol Chem (1998) 1.08
Avian retrovirus nucleocapsid protein, pp12, produced in Escherichia coli has biochemical properties identical to unphosphorylated viral protein. Gene (1986) 1.06
Characterization of the nuclear localization signal in the avian sarcoma virus integrase. Gene (1998) 1.06
Enhanced and coordinated processing of synapsed viral DNA ends by retroviral integrases in vitro. Genes Dev (1995) 1.05
Divalent cations stimulate preferential recognition of a viral DNA end by HIV-1 integrase. Biochemistry (1999) 1.04
Genetic selection for balanced retroviral splicing: novel regulation involving the second step can be mediated by transitions in the polypyrimidine tract. Mol Cell Biol (1995) 1.04
Atomic resolution structures of the core domain of avian sarcoma virus integrase and its D64N mutant. Biochemistry (1999) 1.04
Analysis of chicken ribosomal RNA genes and construction of lambda hybrids containing gene fragments. Science (1977) 0.99
Integrative recombination--a role for the retroviral reverse transcriptase. Cold Spring Harb Symp Quant Biol (1984) 0.99
Role of DNA end distortion in catalysis by avian sarcoma virus integrase. J Biol Chem (2001) 0.97
Role of the constitutive splicing factors U2AF65 and SAP49 in suboptimal RNA splicing of novel retroviral mutants. J Biol Chem (1998) 0.97
Avian sarcoma-leukosis virus pol-endo proteins expressed independently in mammalian cells accumulate in the nucleus but can be directed to other cellular compartments. J Virol (1988) 0.95
In situ immunoassays for translation products. Methods Enzymol (1979) 0.95
Mutational analysis of the substrate binding pockets of the Rous sarcoma virus and human immunodeficiency virus-1 proteases. J Biol Chem (1994) 0.93
Computational analysis of retrovirus-induced scid cell death. J Virol (2001) 0.92
Programming the Rous sarcoma virus protease to cleave new substrate sequences. J Biol Chem (1996) 0.91
Simultaneous observation of quinacrine bands and silver grains on radiolabeled metaphase chromosomes. Histochemistry (1978) 0.91
Rapid solution assays for retroviral integration reactions and their use in kinetic analyses of wild-type and mutant Rous sarcoma virus integrases. Proc Natl Acad Sci U S A (1993) 0.90
Characterization of retrovirus-host DNA junctions in cells deficient in nonhomologous-end joining. J Virol (2001) 0.87
The alpha and beta chains of avian retrovirus reverse transcriptase independently expressed in Escherichia coli: characterization of enzymatic activities. Proc Natl Acad Sci U S A (1988) 0.86
Integration of Rous sarcoma virus DNA into chicken embryo fibroblasts: no preferred proviral acceptor site in the DNA of clones of singly infected transformed chicken cells. J Virol (1981) 0.85
Characterization of the self association of Avian sarcoma virus integrase by analytical ultracentrifugation. J Biol Chem (1999) 0.84
An inhibitory monoclonal antibody binds at the turn of the helix-turn-helix motif in the N-terminal domain of HIV-1 integrase. J Biol Chem (2000) 0.82
Structural basis for inactivating mutations and pH-dependent activity of avian sarcoma virus integrase. J Biol Chem (1998) 0.81
Monoclonal antibodies against Rous sarcoma virus integrase protein exert differential effects on integrase function in vitro. J Virol (1995) 0.80
Antisera to the variable region of ras oncogene proteins, and specific detection of H-ras expression in an experimental model of chemical carcinogenesis. Oncogene (1987) 0.80